Active Free Radical Cold Atmosphere Plasma Promotes Healing of Diabetes Foot Ulcer: Mechanism and Challenge.
Diabetic foot ulcers are a serious complication of diabetes that can lead to disability or even death, and many patients do not respond well to current treatments. This review paper looked at a new therapy called Cold Atmosphere Plasma (CAP), which uses ionized gas to produce reactive oxygen and nitrogen species that fight bacteria and help wounds heal. The researchers reviewed laboratory studies and some animal tests, showing that CAP can kill bacteria, promote cell growth, and reduce inflammation in diabetic foot ulcers. However, they found that there is a lack of high-quality clinical trials in humans, so it is not yet proven to work in real patients. The main benefit is that CAP might be effective without causing drug resistance, which is a big problem for patients needing long-term antibiotics. Still, more research is needed before it can be recommended as a standard treatment.
Key takeaways
- Diabetic foot ulcers are hard to heal and can cause serious harm; new treatments are needed.
- Cold Atmosphere Plasma (CAP) produces reactive species that kill bacteria and promote healing in lab studies.
- CAP shows promise in reducing antibiotic resistance, a major concern for DFU patients.
- However, there are few clinical trials, so its effectiveness in humans is not yet confirmed.
- If you have a DFU, ask your doctor about CAP as a possible clinical trial option.
- Tell your doctor about any wounds that are not healing and discuss all treatment options.
Editor's note
This review highlights an emerging therapy that could offer hope for patients with diabetic foot ulcers in China, especially those with antibiotic-resistant infections. While CAP is not yet widely available, some specialized DFU centers may offer it through clinical research. Patients should ask their healthcare providers about CAP clinical trials and consider participating if eligible to help advance this promising treatment.